Kenneth Weisiger
Pulmonary Disease · Lakewood, CONPI 1376504670
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Mylan Specialty L.p. accounts for 77.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $4,733 and has fallen 90.5% since, to $451 in 2025.
Across 144 payments — averaging $78.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Specialty L.p.$9K
- GSK$906
- Grifols USA, LLC$525
- Sunovion Pharmaceuticals Inc.$235
- AstraZeneca$209
- Pulmonx Corporation$115
- plus $537 from 14 others
What the payments were for
- Consulting fees$1,70515%
- Speaking & faculty fees$6,12054%
- Travel & lodging$5014%
- Food & beverage$3,01527%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mylan Specialty L.p. | 30 | $8,814 |
| GSK | 27 | $906 |
| Grifols USA, LLC | 35 | $525 |
| Sunovion Pharmaceuticals Inc. | 14 | $235 |
| AstraZeneca | 9 | $209 |
| Pulmonx Corporation | 1 | $115 |
| Electromed, Inc. | 7 | $113 |
| Inspire Medical Systems, Inc. | 2 | $79 |
| Inogen, Inc. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Advanced Respiratory, Inc | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $36 |
| Philips North America LLC | 2 | $34 |
| Circassia Inc. | 2 | $32 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| Breathe Technologies, Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Resmed Corp | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yupelri$8,576
- NUCALA$352
- TRELEGY ELLIPTA$121
- Pulmonx Endobronchial Valve EBV$115
How this compares
$11,342 in reported general payments places this provider in the 80th percentile of 248 pulmonary disease providers in Colorado.
Other pulmonary disease in Lakewood
- Michael WechslerDenver$2.7M
- Ronald BalkissoonDenver$1.2M
- David SchwartzAurora$471K
- Vamsi GunturDenver$310K
- Kevin BrownDenver$299K
- Rebecca KeithDenver$248K
- Joshiah GordonPueblo$208K
- Marjorie GeorgeDenver$192K
- Everett SutherlandDenver$174K
- Charles DaleyDenver$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.